Stockreport

Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF SAN MATEO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics [Read more]